| Company Name: |
InvivoChem Gold |
| Tel: |
13549236410 |
| Email: |
sales@invivochem.cn |
Pentixafor manufacturers
- Pentixafor
-
-
2026-07-27
- CAS:1341207-62-2
- Purity:
- Supply Ability: 10g
|
| | Pentixafor Basic information |
| Product Name: | Pentixafor | | Synonyms: | Pentixafor;CPCR4-2;1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[[4-[[[3-[(2R,5S,8S,14R)-5-[3-[(aminoiminomethyl)amino]propyl]-14-[(4-hydroxyphenyl)methyl]-1-methyl-8-(2-naphthalenylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadec-2-yl]propyl]amino]carbonyl]phenyl]methyl]amino]-2-oxoethyl]...;Pentixafor(CPCR4-2);2,2',2''-(10-[2-[([4-[(3-[(2R,5S,8S,14R)-5-(3-Carbamimidamidopropyl)-14-[(4-hydroxyphenyl)methyl]-1-methyl-8-[(naphthalen-2-yl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl]propyl)carbamoyl]phenyl]methyl)amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid | | CAS: | 1341207-62-2 | | MF: | C60H80N14O14 | | MW: | 1221.36 | | EINECS: | | | Product Categories: | | | Mol File: | 1341207-62-2.mol |  |
| | Pentixafor Chemical Properties |
| form | Solid | | color | White to off-white | | InChIKey | OSUJVKAXNLHVRB-HUMWUIFSSA-N |
| | Pentixafor Usage And Synthesis |
| Uses | Pentixafor is a PET imaging agent used in the analysis of CXCR4 receptors in cancer. | | in vivo | [68Ga]Pentixafor (15 MBq, intravenous injection, single dose) is suitable for PET imaging in the PC-3 prostate cancer xenograft model[2].
[18F]AlF-NOTA-Pentixather (0.30 MBq, intravenous injection, single dose) can target the CXCR4 receptor for specific PET imaging in the Daudi lymphoma xenograft SCID mouse model[4].
| Animal Model: | PC-3 prostate cancer xenograft (nude mouse) model[2] | | Dosage: | 15 MBq (Pentixafor labeled with 68Gallium (68Ga), [68Ga]Pentixafor) | | Administration: | Intravenous injection (i.v., injection via tail vein), single dose | | Result: | Resulted in moderate contrast in PET imaging performed in the PC-3 tumor model. |
| Animal Model: | Daudi lymphoma xenograft (SCID mouse) model[4] | | Dosage: | 0.30 MBq ([18F]AlF-NOTA-Pentixather, approx. 195 pmol/0.251 μg) | | Administration: | Intravenous injection (i.v.), single dose, imaging performed at 60 minutes post-injection | | Result: | Exhibited CXCR4-specific tumor accumulation, with low uptake in background organs. |
|
| | Pentixafor Preparation Products And Raw materials |
|